Boehme S A, Lenardo M J
Biological Response Modifiers Program, National Cancer Institute, National Institutes of Health, Bethesda, Md 20892.
Eur J Immunol. 1993 Jul;23(7):1552-60. doi: 10.1002/eji.1830230724.
We found that mature nontransformed CD4+ and CD8+ T lymphocytes could be made susceptible to T cell receptor(TcR)-mediated apoptosis by pretreatment with interleukin-4 (IL-4) or interleukin-2 (IL-2). The degree of susceptibility to death could be correlated with the level of cell cycling as measured by thymidine incorporation, cell doubling times, or the number of cells incorporating bromodeoxyuridine during S phase. However, using pharmacologic cell cycle blocking agents, we found that progression through the cell cycle was not required for cell death. Rather, we found that cells must be in a certain phase of the cell cycle to be susceptible to TcR-mediated death. Cells blocked in G1 phase were resistant to T cell receptor-induced apoptosis, whereas cells blocked in S phase were susceptible. These observations suggest that an important feature of growth lymphokines is their ability to drive T cells into portions of the cell cycle where they are sensitive to antigen receptor-induced apoptosis. Furthermore, these results provide additional evidence that the T cell growth lymphokines IL-2 and IL-4 may participate in the down-regulation of T cell responses by apoptosis-a pathway we have termed "propriocidal regulation".
我们发现,通过白细胞介素-4(IL-4)或白细胞介素-2(IL-2)预处理,成熟的未转化CD4+和CD8+ T淋巴细胞可变得易于发生T细胞受体(TcR)介导的凋亡。死亡易感性程度可与通过胸苷掺入、细胞倍增时间或S期掺入溴脱氧尿苷的细胞数量所测定的细胞周期水平相关。然而,使用药理学细胞周期阻断剂,我们发现细胞死亡并不需要通过细胞周期进程。相反,我们发现细胞必须处于细胞周期的特定阶段才易于发生TcR介导的死亡。G1期阻断的细胞对T细胞受体诱导的凋亡具有抗性,而S期阻断的细胞则易于发生凋亡。这些观察结果表明,生长淋巴因子的一个重要特征是它们能够将T细胞驱动到细胞周期中对抗原受体诱导的凋亡敏感的部分。此外,这些结果提供了额外的证据,表明T细胞生长淋巴因子IL-2和IL-4可能通过凋亡参与T细胞反应的下调——我们将这一途径称为“自身杀伤调节”。